Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report

Journal of Medical Case Reports - United Kingdom
doi 10.1186/s13256-017-1404-2
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis

Journal of Neurology
Neurology
2017English

Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report

American Journal of Hematology
Hematology
2017English

Intravenous Thrombolysis for Suspected Ischemic Stroke With Seizure at Onset

Annals of Neurology
Neurology
2019English

Thyroid Hemorrhage Causing Airway Obstruction After Intravenous Thrombolysis for Acute Ischemic Stroke

Neurocritical Care
Critical CareNeurologyIntensive Care Medicine
2013English

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke

Frontiers in Neurology
Neurology
2019English

Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Mechanical Thrombectomy After Intravenous Thrombolysis for Acute Ischaemic Stroke

The Lancet Neurology
Neurology
2017English

Blood Pressure Variability and Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke

Journal of Neurology and Neuromedicine
2016English

Idarucizumab Resistance Due to a Markedly Elevated Dabigatran Concentration – A Case Report

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy